Indole RSK inhibitors. Part 1: discovery and initial SAR.

[1]  S. Goueli,et al.  ADP-Glo: A Bioluminescent and homogeneous ADP monitoring assay for kinases. , 2009, Assay and drug development technologies.

[2]  K. Parris,et al.  Identification and SAR of squarate inhibitors of mitogen activated protein kinase-activated protein kinase 2 (MK-2). , 2009, Bioorganic & medicinal chemistry.

[3]  Yuji Arai,et al.  Activation of Na (cid:1) /H (cid:1) Exchanger 1 Is Sufficient to Generate Ca 2 (cid:1) Signals That Induce Cardiac Hypertrophy and Heart Failure , 2022 .

[4]  J. Blenis,et al.  The RSK family of kinases: emerging roles in cellular signalling , 2008, Nature Reviews Molecular Cell Biology.

[5]  T. Nguyen.  Targeting RSK: an overview of small molecule inhibitors. , 2008, Anti-cancer agents in medicinal chemistry.

[6]  C. Somps,et al.  Na+/H+ exchanger-1 inhibitors reduce neuronal excitability and alter na+ channel inactivation properties in rat primary sensory neurons. , 2008, Toxicological sciences : an official journal of the Society of Toxicology.

[7]  J. Arezzo,et al.  Neurotoxic Effects of Zoniporide: A Selective Inhibitor of the Na+/H+ Exchanger Isoform 1 , 2008, Toxicologic pathology.

[8]  J. Blenis,et al.  The RSK factors of activating the Ras/MAPK signaling cascade. , 2008, Frontiers in bioscience : a journal and virtual library.

[9]  S. Javadov,et al.  The role of NHE-1 in myocardial hypertrophy and remodelling. , 2008, Journal of molecular and cellular cardiology.

[10]  G. Buckberg,et al.  Sodium-hydrogen exchange inhibition by cariporide to reduce the risk of ischemic cardiac events in patients undergoing coronary artery bypass grafting: results of the EXPEDITION study. , 2008, The Annals of thoracic surgery.

[11]  M. Avkiran,et al.  Targeting Na+/H+ exchanger regulation for cardiac protection: a RSKy approach? , 2008, Current opinion in pharmacology.

[12]  M. Hao,et al.  Synthesis and SAR studies of indole-based MK2 inhibitors. , 2008, Bioorganic & medicinal chemistry letters.

[13]  M. Hao,et al.  Pyrazinoindolone inhibitors of MAPKAP-K2. , 2008, Bioorganic & medicinal chemistry letters.

[14]  S. Munshi,et al.  Crystal structures of the N‐terminal kinase domain of human RSK1 bound to three different ligands: Implications for the design of RSK1 specific inhibitors , 2007, Protein science : a publication of the Protein Society.

[15]  Michel Emmanuel,et al.  The discovery of carboline analogs as potent MAPKAP-K2 inhibitors. , 2007, Bioorganic & medicinal chemistry letters.

[16]  S. Semus,et al.  Discovery of aminofurazan-azabenzimidazoles as inhibitors of Rho-kinase with high kinase selectivity and antihypertensive activity. , 2007, Journal of medicinal chemistry.

[17]  J. Abe,et al.  Inhibiting p90 Ribosomal S6 Kinase Prevents Na+-H+ Exchanger–Mediated Cardiac Ischemia-Reperfusion Injury , 2006, Circulation.

[18]  M. Karmazyn,et al.  The Na(+)/H(+) exchanger: a target for cardiac therapeutic intervention. , 2005, Current drug targets. Cardiovascular & haematological disorders.

[19]  M. Avkiran,et al.  Effects of bisindolylmaleimide PKC inhibitors on p90RSK activity in vitro and in adult ventricular myocytes , 2005, British journal of pharmacology.

[20]  J. Silber,et al.  Functional Characterization of Human RSK4, a New 90-kDa Ribosomal S6 Kinase, Reveals Constitutive Activation in Most Cell Types* , 2005, Journal of Biological Chemistry.

[21]  M. Karmazyn,et al.  Activation of Na+/H+ Exchanger-directed Protein Kinases in the Ischemic and Ischemic-reperfused Rat Myocardium* , 2001, The Journal of Biological Chemistry.

[22]  M. Karmazyn,et al.  The myocardial Na(+)-H(+) exchange: structure, regulation, and its role in heart disease. , 1999, Circulation research.

[23]  G. Binsch,et al.  Ring inversion barrier in 5,5-difluoro-1,3-dioxane , 1973 .

[24]  M. Kashem,et al.  Indole RSK inhibitors. Part 2: optimization of cell potency and kinase selectivity. , 2012, Bioorganic & medicinal chemistry letters.

[25]  Zigang Dong,et al.  Structural basis for activation of the autoinhibitory C-terminal kinase domain of p90 RSK2 , 2008, Nature Structural &Molecular Biology.

[26]  J. Greve,et al.  Abstracts of papers , 2005, Pharmaceutisch Weekblad.

[27]  L. Harwood,et al.  The direct synthesis of the cyclic sulphamidate of (S)-prolinol: SimultaneousN-protection and activation towards nucleophilic displacement of oxygen. , 1990 .